Literature DB >> 23894906

Role of probiotics in health and disease: a review.

Varun Pratap Singh1, Jagannath Sharma, Shankar Babu, Anshul Singla.   

Abstract

For some decades now, bacteria known as probiotics have been added to various foods because of their beneficial effects for human health. The mechanism of action of probiotics is related to their ability to compete with pathogenic microorganisms for adhesion sites, to antagonize these pathogens or to modulate the host's immune response. The potential application of probiotics includes prevention and treatment of various health conditions and diseases such as gastrointestinal infections, inflammatory bowel disease, lactose intolerance, allergies, urogenital infections, cystic fibrosis, various cancers, reduction of antibiotic side effects, in oral health such as prevention of dental caries, periodontal diseases and oral malodour and many other effects which are under investigation. The results of many of these clinical investigations suggests that probiotics may be useful in preventing and treating various health conditions and diseases. However, many of these clinical studies require validation so as to apply these results to clinical realm. The role of clinical trials is instrumental in such investigations and in near future the results of such trials will decide the usefulness of probiotics in health and disease. This article strives to summarize the currently available data on the potential benefits of probiotics in health and disease.

Entities:  

Mesh:

Year:  2013        PMID: 23894906

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  29 in total

Review 1.  Antihypertensive Effects of Probiotics.

Authors:  Iñaki Robles-Vera; Marta Toral; Miguel Romero; Rosario Jiménez; Manuel Sánchez; Francisco Pérez-Vizcaíno; Juan Duarte
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

2.  The impact of heterologous catalase expression and superoxide dismutase overexpression on enhancing the oxidative resistance in Lactobacillus casei.

Authors:  Jinzhong Lin; Yexia Zou; Kunlin Cao; Chengjie Ma; Zhengjun Chen
Journal:  J Ind Microbiol Biotechnol       Date:  2016-02-27       Impact factor: 3.346

3.  PrimiOtic and PrimiOtic Plus: novel probiotic for primates suffering from idiopathic chronic diarrhea.

Authors:  Jaime L Lecker; Karen Froberg-Fejko
Journal:  Lab Anim (NY)       Date:  2015-10       Impact factor: 12.625

4.  Targeted and Repetitive Chromosomal Integration Enables High-Level Heterologous Gene Expression in Lactobacillus casei.

Authors:  Yongping Xin; Yingli Mu; Jian Kong; Tingting Guo
Journal:  Appl Environ Microbiol       Date:  2019-04-18       Impact factor: 4.792

5.  Milk and Dairy Product Consumption and Bladder Cancer Risk: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Laura M Bermejo; Bricia López-Plaza; Cristina Santurino; Iván Cavero-Redondo; Carmen Gómez-Candela
Journal:  Adv Nutr       Date:  2019-05-01       Impact factor: 8.701

6.  Potential Probiotic Lactic Acid Bacteria with Anti-Penicillium expansum Activity from Different Species of Tunisian Edible Snails.

Authors:  Ghada Rabaoui; Fernando Sánchez-Juanes; Mohamed Tebini; Karim Naghmouchi; Juan Luis Muñoz Bellido; Kamel Ben-Mahrez; Samia Réjiba
Journal:  Probiotics Antimicrob Proteins       Date:  2022-01-13       Impact factor: 4.609

7.  Probiotic supplementation attenuates hippocampus injury and spatial learning and memory impairments in a cerebral hypoperfusion mouse model.

Authors:  Hamideh Rahmati; Shahein Momenabadi; Abbas Ali Vafaei; Ahmad Reza Bandegi; Zohreh Mazaheri; Abedin Vakili
Journal:  Mol Biol Rep       Date:  2019-07-08       Impact factor: 2.316

8.  Targeting the Microbiota, from Irritable Bowel Syndrome to Mood Disorders: Focus on Probiotics and Prebiotics.

Authors:  M M Pusceddu; K Murray; M G Gareau
Journal:  Curr Pathobiol Rep       Date:  2018-02-12

Review 9.  Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing Escherichia coli.

Authors:  Su-Bin Hwang; Ramachandran Chelliah; Ji Eun Kang; Momna Rubab; Eric Banan-MwineDaliri; Fazle Elahi; Deog-Hwan Oh
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

10.  Antimicrobial and Antibiofilm Activities of Weissella cibaria against Pathogens of Upper Respiratory Tract Infections.

Authors:  Ji-Eun Yeu; Hyeon-Gyu Lee; Geun-Yeong Park; Jisun Lee; Mi-Sun Kang
Journal:  Microorganisms       Date:  2021-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.